IMR Press / CEOG / Volume 40 / Issue 2 / pii/1630388179362-1207286365

Clinical and Experimental Obstetrics & Gynecology (CEOG) is published by IMR Press from Volume 47 Issue 1 (2020). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research
Sympathomimetic amines effectively control pain for interstitial cystitis that had not responded to other therapies
Show Less
1 The University of Medicine and Dentistry of New Jersey, Robert Wood Johnson Medical School at Camden Cooper Hospital/University Medical Center, Department of Obstetrics and Gynecology Division of Reproductive Endocrinology & Infertility, Camden, New Jersey (USA)
Clin. Exp. Obstet. Gynecol. 2013, 40(2), 227–228;
Published: 10 June 2013
Abstract

Purpose: To further investigate the efficacy of treatment of interstitial cystitis that had been refractory to standard treatment with sympathomimetic amines. Methods: Dextroamphetamine sulfate sustained release capsules up to 30 mg per day were prescribed in women with refractory painful bladder syndrome/interstitial cystitis in six new cases. The patients were carefully evaluated for relief of symptoms. Results: All six women found marked relief in their painful bladder syndrome in a rather short length of time. The benefit persisted as long as the therapy was maintained. Temporary cessation resulted in prompt return of symptoms, but resumption of sympathomimetic amines again allowed good relief of bladder pain and related symptoms. Conclusions: Because of very few sideeffects and no drug dependence in the dosage used, sympathomimetic amines should be considered for first-line therapy.
Keywords
Sympathomimetic amines
Interstitial cystitis
Sympathetic hypofunction
Neurotransmitter
Acetylcholine
Share
Back to top